Moreover, Miguchi et al. established that an increase in GSDMC expression was linked to mutations in TGF-β receptor type II, and leading to a promotion of cell growth in colorectal cancer and xenograft tumor volum in vivo (Miguchi et al., 2016). This evidence concerns the gene GSDMC and colorectal cancer.